Building Humans, Cell to Organ

Tengion is a leader in the field of regenerative medicine, developing new human tissues and organs derived from a patient’s own cells. Tengion’s patented technology has the potential to allow adults and children with organ failure to have functioning organs built from their own tissues. At the Dow Jones Venture Wire Health Care Innovations conference, PodTech’s Jennifer Jones talks with CEO Steven Nichtberger about how his company is planning to save lives through these scientific advances.

Related posts:

Andy Kessler: End of Health Care as We Know It Venture capitalist Andy Kessler says silicon is going to do to the health care industry what it has done to portable devices and the Internet. Where will it start? With diagnostics, according to Kessler, who delivered the lunch keynote at...

Health Care VC Waiting for Stem Cell Market to Grow Despite President Bush’s veto of the embryonic stem cell bill almost two months ago, many venture capitalists consider the stem cell market to be viable… though just not yet for some investors. When and why will a venture capitalist invest...

Yahoo: Marco Boerries, SVP, Connected Life Yahoo is making headway by being bold and thinking young. Jennifer Jones of PodTech interviews Marco Boerries at the Dow Jones Venture Wire Consumer Technology Ventures Conference about Yahoo’s strategies for connecting users whether they are on the road, at...

Health Innovations: New Cures, New Capital Many exciting biomed startups have found a home in the venture capital market. “Public investors are risk averse these days,” says VentureWire’s Tom Salemi. “They only want to bet on as sure a thing as possible. That’s not usually the...

Venture Capital Insights on Health Care Financing Getting money for a Series B round in health care deals results in a “down round” at least 50 percent of the time. Ralph (Chris) Christoffersen, a general partner at Morgenthaler Ventures, tells PodTech’s Jennifer Jones how his firm helps...

Dow Jones VentureWire Health Care Innovations Conference Change is coming fast for health care investors, executives and entrepreneurs. Public investors have rejected companies built on once-surefire models. Big Pharma, after years of nibbling, is acquiring private drug companies to boost internal pipelines. IT may finally be making...

Building a Corporate Culture for Social Media The best company cultures that work for social media are just like people who embrace conversations and two-way interactions — they are open, trusting and talkative. Jennifer McClure, executive director of the Society for New Communications Research talks to Marketing...